NEVE ILAN, Israel, July 01, 2021 (GLOBE NEWSWIRE) — NANO-X IMAGING LTD (NASDAQ: NNOX) (“Nanox” or the “Company”), an innovative medical imaging technology company, today announces that Nanox’s Chairman and Chief Executive Officer Ran Poliakine will deliver a company presentation and the leadership team will host investor 1×1 meetings during the Ladenburg Thalmann Healthcare Conference, which is being held July 13th through July 14th.
Mr. Poliakine’s presentation is scheduled for Wednesday, July 14, at 10:00am ET. The presentation will be accessible via a live webcast at: https://wsw.com/webcast/ladenburg7/nani/2400962.
Interested parties can also access the live audio webcast for this conference from the Investor Relations section of the Company’s website at www.nanox.vision. The webcast replay will be available after the conclusion of the live presentation.
About NANO-X:
Nanox, founded by the serial entrepreneur Ran Poliakine, is an Israeli corporation that is developing a commercial-grade digital X-ray source designed to be used in real-world medical imaging applications. Nanox believes that its novel technology could significantly reduce the costs of medical imaging systems and plans to seek collaborations with world-leading healthcare organizations and companies to provide affordable, early detection imaging service for all. For more information, please visit www.nanox.vision.
Investors
Itzhak Maayan
Nanox Imaging
IR@nanox.vision
Bob Yedid
LifeSci Advisors
646-597-6989
bob@lifesciadvisors.com
Company to present key research advancing digital pathology and host a networking event, H&E by…
LiveWorld looks to increase its AI investmentCAMPBELL, Calif. and NEW YORK , March 25, 2025…
The Acquisition is Expected to Create Immediate Synergies with the Company’s Existing Medical Device Business …
SUN CITY, Ariz., March 25, 2025 (GLOBE NEWSWIRE) -- Emerald Isle Health & Recovery proudly…
AGOURA HILLS, Calif., March 25, 2025 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc (OTCQB:OTLC) ("Oncotelic", the…
Diabetinol® is a clinically supported and patented plant-based nutraceutical product targeting the pre-diabetic and weight…